The Pharma Industry’s Sustainability Commitment So Far
In response to calls for change, global pharma organisations have made ambitious sustainability commitments which are based in science; this lets them chart progress against frameworks such as the Science Based Targets initiative (SBTi) and the Dow Jones Sustainability Index. This helps business translate their commitment into concrete action across manufacturing, supply chain operations and product lifecycle management, letting them communicate exactly how their efforts measure up.
Collaboration is key to achieving these goals, and international organisations like the European Federation of Pharmaceutical Industries and Associations (EFPIA) demonstrate just how aligned many companies have become on sustainability. One recent report points out that the group’s membership has tripled its consumption [2] of renewable electricity in five years, representing a dramatic shift from fossil-based fuels to biogas, biomass, and renewable electricity.
What’s more, the pharmaceutical industry's journey towards sustainability encompasses the entire value chain. Companies are integrating ESG frameworks into their core operations, supported by national and global associations which encourage a more holistic approach to responsible sourcing, efficient waste management and energy conservation [3] at every relevant stage of the process.
Exploring Sustainable Innovation in Pharmaceutical Packaging
Packaging represents a key frontier in improving the pharma industry’s sustainability efforts. Although its contributions to overall emissions are low, modernising pharmaceutical packaging presents significant opportunities to advance the circular economy and reduce waste production.
Innovation in Circular Design
Pharma companies are actively exploring new materials, prioritising those which provide a recyclable or biodegradable alternative to tried-and-tested plastic packaging. For example, blister packs, one of the most common pharmaceutical formats, have unsurprisingly been at the forefront of innovation where sustainability is concerned. Established designs are being further streamlined [4] to remove materials which cannot be easily recycled. Meanwhile, advanced solutions such as recyclable PET and HDPE materials, combined with eco-friendly inks, demonstrate that sustainability and regulatory compliance can coexist effectively.
Lightweighting and Material Efficiency
With materials now being carefully chosen for their sustainability as well as their efficacy and integrity, supply chains need to balance the benefits. For example, advances in pharma-grade HDPE resins [5] now allow for bottles to be 30% lighter with no impact on its moisture barrier properties. This reduces consumption of materials, lowering production costs and shipping weight, showing the tangible benefits from pursuing sustainable goals.
Post-consumer recycled (PCR) plastic is gaining traction as pharmaceutical companies gradually use them to replace virgin plastic packaging. This approach supports a circular economy where materials are reused rather than discarded, reducing environmental harm and decreasing the overall consumption of new plastics.
Transforming Supply Chain Logistics to Reduce Pharma’s Carbon Footprint
Each component of the pharma supply chain has faced scrutiny to scale up its sustainability measures and find environmentally friendly alternatives to its existing processes. Logistics accounts for more than 70% [6] of pharma’s total Scope 3 emissions, suggesting that there is plenty of opportunity for improvements to be made.
The Challenges of Sustainable Cold Chain Logistics
Cold chain technology is essential for maintaining the pharmaceutical potency of temperature-sensitive medications, but carries enormous environmental costs, including high energy consumption from refrigerated warehouses and transport vehicles and waste from single-use plastics and non-biodegradable insulation materials.
The industry is responding with green innovations that to reduce the pharma supply chain’s carbon footprint in ways which allow operations to continue without compromising product integrity:
Solar-Powered Refrigeration: Renewable energy-powered cooling systems reduce dependence on grid electricity and fossil fuels.
Phase Change Materials: Advanced insulation technologies maintain temperature control with reduced energy consumption compared to traditional refrigeration.
Reusable Packaging Systems: Durable, returnable cold chain containers eliminate single-use packaging waste whilst maintaining temperature integrity.
Route Optimisation Technologies: AI-powered logistics planning can minimise transportation distances, reduce fuel consumption and improve the overall efficiency of deliveries.
Sustainable Transportation Strategies
Logistics companies have begun touting the introduction of low-or-no-emission vehicles, incorporating electric and hybrid vans to their delivery fleets. Routes are also being planned to minimise the emission of greenhouse gases, often shifting to rail or ocean routes rather than traditional motorway freighting.
Combined with energy-efficient warehousing, green transportation strategies [7] are reducing power consumption and operational emissions across the pharma distribution network. These initiatives deliver multiple benefits, from the lower operating costs of reduced energy and waste, to improved brand image and consumer trust, regulatory compliance with environmental standards and, crucially, a more resilient and efficient pharmaceutical supply chain.
